Immunohistochemistry analyses of tumor cell proliferation (Ki-67) and apoptosis (cleaved caspase 3, CC3) showed a reduction in proliferating cells (Figure 7C,E) along with higher cleaved caspase 3 rates in all of the treatment groups (Figure 7C,F). This evidence concerns the gene MKI67 and neoplasm.